UNSPSC 51182066: Testosterone benzoate

This classification denotes an androgen with the molecular formula C26H32O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 387187KT3E, chemically known as androst-4-en-3-one, 17-(benzoyloxy)-, (17.beta.)-, but more generally known as testosterone benzoate, which bears US NIH Compound Identifier 101474. European Medicines Agency schedules testosterone benzoate or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10937MIG.

Most nations, for tariff purposes, schedule testosterone benzoate under HS 29372900. SMILES: C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2OC(=O)C4CCCCC4)CCC5=CC(=O)CC[C@]35C.

UNSPSC 51182066 Testosterone benzoate is a Commodity code tracking procurement of a pharmaceutical steroid compound used in hormone replacement therapy, clinical treatment protocols, and related medical applications by state and local health departments, correctional facilities, and public health agencies. State and local governments purchase testosterone benzoate primarily through contracted pharmaceutical suppliers, often as part of broader formulary management or institutional medical supply agreements. The code covers acquisition of the active pharmaceutical ingredient or finished pharmaceutical preparations for use in public health clinics, correctional medical services, and state hospital systems.

The most recent state and local contract opportunities block contains no records for this code, indicating minimal or no current procurement activity under UNSPSC 51182066 at the state and local level. Without recent solicitation data, geographic spread and issuing-body patterns cannot be characterized from current market activity.